البلد: الولايات المتحدة
اللغة: الإنجليزية
المصدر: NLM (National Library of Medicine)
HYDROMORPHONE HYDROCHLORIDE (UNII: L960UP2KRW) (HYDROMORPHONE - UNII:Q812464R06)
Lannett Company, Inc.
ORAL
PRESCRIPTION DRUG
Hydromorphone hydrochloride oral solution is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see Warnings and Precautions ( 5.2 )] , reserve hydromorphone hydrochloride oral solution for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: - Have not been tolerated, or are not expected to be tolerated, - Have not provided adequate analgesia, or are not expected to provide adequate analgesia Hydromorphone hydrochloride oral solution is contraindicated in patients with: - Significant respiratory depression [see Warnings and Precautions ( 5.7 )] Significant respiratory depression [see Warnings and Precautions ( 5.7 )] - Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see Warnings and Precautio
Hydromorphone Hydrochloride Oral Solution, USP is a clear, colorless liquid. It is available in: Bottles of 1 pint (473 mL): NDC 0527-1873-47 STORAGE : Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light. Store hydromorphone hydrochloride oral solution securely and dispose of properly [see Patient Counseling Information (17)] .
Abbreviated New Drug Application
Lannett Company, Inc. ---------- MEDICATION GUIDE Hydromorphone Hydrochloride (hy-dro-MOR-fone hy-dro-KLOR-ide) Oral Solution, USP, CII Hydromorphone Hydrochloride Oral Solution is: • Strong prescription pain medicine that contains an opioid (narcotic) that is used to manage pain severe enough to require an opioid analgesic, when other pain treatments such as non-opioid pain medicines do not treat your pain well enough or you cannot tolerate them. • Opioid pain medicine that can put you at risk for overdose and death. Even if you take your dose correctly as prescribed you are at risk for opioid addiction, abuse, and misuse that can lead to death. Important information about Hydromorphone Hydrochloride Oral Solution: • Get emergency help right away if you take too much Hydromorphone Hydrochloride Oral Solution (overdose). When you first start taking Hydromorphone Hydrochloride Oral Solution, when your dose is changed, or if you take too much (overdose), serious or life-threatening breathing problems that can lead to death may occur. • Taking Hydromorphone Hydrochloride Oral Solution with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, breathing problems, coma, and death. • Never give anyone else your hydromorphone hydrochloride oral solution. They could die from taking it. Selling or giving away hydromorphone hydrochloride oral solution is against the law. • Store hydromorphone hydrochloride oral solution securely, out of sight and reach of children, and in a location not accessible by others, including visitors to the home. Do not take Hydromorphone Hydrochloride Oral Solution if you have: • Severe asthma, trouble breathing, or other lung problems. • A bowel blockage or have narrowing of the stomach or intestines. Before taking Hydromorphone Hydrochloride Oral Solution, tell your healthcare provider if you have a history of: • head injury, seizures ● liver, kidney, thyroid p اقرأ الوثيقة كاملة
HYDROMORPHONE HYDROCHLORIDE- HYDROMORPHONE HYDROCHLORIDE SOLUTION LANNETT COMPANY, INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE HYDROMORPHONE HYDROCHLORIDE ORAL SOLUTION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR HYDROMORPHONE HYDROCHLORIDE ORAL SOLUTION. HYDROMORPHONE HYDROCHLORIDE, USP ORAL SOLUTION, CII INITIAL U.S. APPROVAL: JANUARY 1984 WARNING: RISK OF MEDICATION ERRORS; ADDICTION, ABUSE, AND MISUSE; RISK EVALUATION AND MITIGATION STRATEGY (REMS); LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING_. ENSURE ACCURACY WHEN PRESCRIBING, DISPENSING, AND ADMINISTERING HYDROMORPHONE HYDROCHLORIDE ORAL SOLUTION. DOSING ERRORS DUE TO CONFUSION BETWEEN MG AND ML CAN RESULT IN ACCIDENTAL OVERDOSE AND DEATH. (2.1, 5.1) HYDROMORPHONE HYDROCHLORIDE ORAL SOLUTION EXPOSES USERS TO RISKS OF ADDICTION, ABUSE, AND MISUSE, WHICH CAN LEAD TO OVERDOSE AND DEATH. ASSESS PATIENT’S RISK BEFORE PRESCRIBING AND MONITOR REGULARLY FOR THESE BEHAVIORS AND CONDITIONS. (5.2) TO ENSURE THAT THE BENEFITS OF OPIOID ANALGESICS OUTWEIGH THE RISKS OF ADDICTION, ABUSE, AND MISUSE, THE FOOD AND DRUG ADMINISTRATION (FDA) HAS REQUIRED A RISK EVALUATION AND MITIGATION STRATEGY (REMS) FOR THESE PRODUCTS. (5.3) SERIOUS, LIFE-THREATENING, OR FATAL RESPIRATORY DEPRESSION MAY OCCUR. MONITOR CLOSELY, ESPECIALLY UPON INITIATION OR FOLLOWING A DOSE INCREASE. (5.4) ACCIDENTAL INGESTION OF HYDROMORPHONE HYDROCHLORIDE ORAL SOLUTION, ESPECIALLY BY CHILDREN, CAN RESULT IN A FATAL OVERDOSE OF HYDROMORPHONE. (5.4) PROLONGED USE OF HYDROMORPHONE HYDROCHLORIDE ORAL SOLUTION DURING PREGNANCY CAN RESULT IN NEONATAL OPIOID WITHDRAWAL SYNDROME, WHICH MAY BE LIFE-THREATENING IF NOT RECOGNIZED AND TREATED. IF PROLONGED OPIOID USE IS REQUIRED IN A PREGNANT WOMAN, ADVISE THE PATIENT OF THE RISK OF NEO اقرأ الوثيقة كاملة